Search for: "Pharmaceutical Product Development, Inc."
Results 41 - 60
of 1,240
Sorted by Relevance
|
Sort by Date
25 Nov 2020, 10:21 am
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, reportedly engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. [read post]
1 Dec 2021, 1:29 pm
Pfizer, Inc. [read post]
1 Jun 2017, 9:22 am
Wasserman Rajec* In Impression Products, Inc. v. [read post]
15 Sep 2014, 6:40 am
In the Freeman case, the plaintiff filed her lawsuit in early 2009 against Wyeth Pharmaceuticals Inc. [read post]
30 Jan 2016, 12:28 pm
While investments in big name pharmaceuticals with diversified portfolios of established drugs and products offer greater stability some brokers recommend small bio-technology companies that have only one or two unproven drugs in clinical trials or development. [read post]
4 Sep 2012, 7:04 am
Watson Pharmaceuticals, Inc., No. 10-12729 (11th Cir. [read post]
10 Oct 2014, 12:00 pm
(“BMS”) and Otsuka America Pharmaceutical Inc. [read post]
3 Dec 2008, 10:25 am
Jude Medical, Inc. [read post]
13 Feb 2009, 9:43 pm
GSK Licenses HIV Drug Candidate GlaxoSmithKline and Idenix Pharmaceuticals, Inc. have announced that GSK has licensed worldwide... [read post]
7 Jul 2010, 11:10 am
Inc. v. [read post]
17 Jun 2010, 6:47 am
Abbott Laboratories, Inc. [read post]
12 Jun 2008, 4:45 am
Astrazeneca developed... [read post]
28 Sep 2012, 11:15 am
We have written previously on numerous developments concerning reverse payments in Hatch-Waxman litigation settlements (i.e., payments made by branded pharmaceutical patent holders to generic challengers to postpone market entry of proposed generic products). [read post]
1 May 2007, 8:23 am
The suit was dismissed without prejudice in light of the settlement.Hydromer, Inc. is a technology-based company involved in the research and development, manufacture and commercialization of specialized polymer and hydrogel products for medical device, pharmaceutical, animal health, cosmetic, personal care, and industrial uses. [read post]
5 Aug 2016, 2:10 pm
The use of these proton pump inhibitors (PPIs) for as little as a couple of weeks can result in an increased risk of developing: Acute Interstitial Nephritis (AIN) Chronic Kidney Disease (CKD) End-Stage Renal Disease (ESRD) Severe Renal Impairment Kidney / Renal Failure Acute Kidney Injury We are currently investigating possible drug injury lawsuits against the responsible pharmaceutical companies for patients using these drugs who have developed the side effects… [read post]
19 Oct 2010, 7:31 am
(Nasdaq: SOMX), a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the website of the U.S. [read post]
25 Mar 2007, 9:19 pm
Following a successful patent defense on Zyprexa, Lilly now faces challenges to Gemzar (gemcitabine, an injectible chemotherapy that treats several forms of cancer) from Sicor Pharmaceuticals Inc., Mayne Pharma Inc. and Sun Pharmaceutical Industries Inc. through challenges mounted via provisions of the Hatch-Waxman Act. [read post]
18 Apr 2018, 1:02 pm
In Teva Pharmaceutical USA, Inc. v. [read post]
23 Jan 2011, 5:37 pm
Since Dec. 3, seven lawsuits have been filed in federal court alleging that Xanodyne Pharmaceuticals Inc., the manufacturer of Darvocet and Darvon, knew of the risks but failed to warn doctors and the general public that the medications could contribute to heart disease. [read post]
25 Oct 2009, 9:00 am
The complaint was filed in the Superior Court of New Jersey, where Bayer Healthcare Pharmaceuticals, Inc., is located. [read post]
